| Hyperpara | ||
| Author | Date | Comments |
| Messa | 98 | 81 pts, those with high PTH a year post tx had hx longer time on HD and higher pre-tx PTH levels; some relationship to VDR genotypes seen |
| D'Alessandro | 89 | between '81&'87 tx in 1025 pts, 819 survived, 1.8% had PTX mean time 18 mo post tx; 29% had hypercalcemia, of those 25% persisted longer than 7 yrs |
| Leunissen | 86 | 2 pts with posttransplant high PTH treated with po pamidronate and improved, PTH also fell |
| Vezzoli | 86 | xs study of pts 4 yrs post tx found high iCa in 66% |
| Cundy | 83 | pros obs of 100 pts for 2 yrs, 36% developed high calcium, mean onset 148 days, assoc with longer time on dialysis and high PTH |
| Memmos | 82 | report their series of PTX |
| McCarron | 80 | PTH-calcium curves in tx pts show higher baseline but similar shape, suggeting hyperplasia as mechanism |
| David | 73 | reviewed 64 pts who had successful renal tx, 34% hypercalcemia, 86% within the first year, persisited in 8 of them, all with high PTH. Also more pre-tx metastatic calcif. |
| Alfrey | 68 | 17 pts, hypercalcemia in 9, resolved, bone xrays got better |
| Aluminum | ||
| Briner | 95 | 20 pts, Al 48% to 11% 2 yrs post tx |
| David-Neto | 93 | 11 pts with Al, all improved, necrosis in 6, bxs showed decreased osteoid and al surface, increased bone formation |
| Davenport | 93 | 38 pts followed prospectively who didnt need transfusions; aluminum decreased and hemoglobin increased; Hb incrase greater in those not given al antacids. |
| Betolone | 93 | 20 pts aluminum in bone 63 to 36 mcg/kg; bxs decreased osteoid (but none adynamic in the first place) |
| Dahl | 92 | Al decreased in bxs pre and post tx in PTX as well as non-PTX pts. Poor reasoning about relation of Al to PTX! |
| Nordal | 92 | pros bxs in 55 pts; 10/55 had hypercalcemia; no AVN on standard xrays, cortical thick. decreased, BV same, BFR increased, Al stain decr |
| Piraino | 88 | case report - got better post tx |
| Nordal | 88 | suggest Al helps rejection, bad statistics |
| AVN | ||
| Lausten | 98 | xs study 750 pts, AVN 11.2% in high-dose steroids, average 26 mo p tx, and only 5% in low-dose steroids average 20 mo |
| Holman | 95 | J Rheumatol from UW - find |
| Siddiqui | 93 | some asymptomatic pts with pos MRI resolve; pros study of 72 pts x2yrs, 10 hips nl scan, abn MRI which resolved in 6, no sx; 13 scan abn, MRI nl, resolved in 8; 3 pts had sx and both studies pos |
| Fordyce | 93 | 32 pts, 3 had pos MRI but no sx, one later got sx |
| Churchill | 91 | 29 pts with stage 3 or 4 AVN, mean onset of sx 33 mo post tx, by 3 yrs 60% of hips needed surgery, by 5 yrs 80% |
| Kopecky | 91 | 104 pts, pros x 24 mo, 10 developed MRI pos, 4 of them developed pain. Xrays pos in the 4 with sx. |
| Patton | 88 | 444 pts, 16% got AVN sx, related to steroid dose |
| Landmann | 87 | AVN in 15/174 pre cyclosporin, 1/96 post |
| Spencer | 83 | bone scans showed AVN in 8/42 pts, 7 became symptomatic |
| Nixon | 79 | AVN in 14 of 181 within 4 yrs. |
| Ibels | 78 | 40/184, 21% had symptomatic AVN, 15 of them had surgery |
| Amyloid | ||
| Tan | 96 | KI article - find |
| Barden | 95 | 14 pts tx after ?10 yrs HD, articular sx better in 10, still had amyloid deposits and subchondral bone erosions |
| Jadoul | 89 | amyloid pain improved post tx, maybe due to steroids, no new cysts for 4 yrs but no regression either |